Sofosbuvir and daclatasvir compared with standard of care in the treatment of patients admitted to hospital with moderate or severe coronavirus infection (COVID-19): a randomized controlled trial

BACKGROUND: Currently no effective antiviral therapy has been found to treat COVID-19. The aim of this trial was to assess if the addition of sofosbuvir and daclatasvir improved clinical outcomes in patients with moderate or severe COVID-19. METHODS: This was an open-label, multicentre, randomized c...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Antimicrob Chemother
Main Authors: Sadeghi, Anahita, Ali Asgari, Ali, Norouzi, Alireza, Kheiri, Zahedin, Anushirvani, Amir, Montazeri, Mahnaz, Hosamirudsai, Hadiseh, Afhami, Shirin, Akbarpour, Elham, Aliannejad, Rasoul, Radmard, Amir Reza, Davarpanah, Amir H, Levi, Jacob, Wentzel, Hannah, Qavi, Ambar, Garratt, Anna, Simmons, Bryony, Hill, Andrew, Merat, Shahin
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2020
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7454592/
https://ncbi.nlm.nih.gov/pubmed/32812039
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jac/dkaa334
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados